|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.170 USD | +8.33% |
|
-7.77% | -81.01% |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 29/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 2.58Cr 2.24Cr 2.08Cr 1.92Cr 3.62Cr 246.69Cr 3.69Cr 25Cr 9.66Cr 122.52Cr 9.7Cr 9.49Cr 412.02Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 2.58Cr 2.24Cr 2.08Cr 1.92Cr 3.62Cr 246.69Cr 3.69Cr 25Cr 9.66Cr 122.52Cr 9.7Cr 9.49Cr 412.02Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +7.60% | ||
| 1 week | -7.77% | ||
| Current month | -24.05% | ||
| 1 month | -24.05% | ||
| 3 months | -60.47% | ||
| 6 months | -75.33% | ||
| Current year | -81.01% |
| 1 week | 1.03 |  | 1.25 |
| 1 month | 1.03 | | 1.95 |
| Current year | 1.03 | | 7.05 |
| 1 year | 1.03 | | 9.22 |
| 3 years | 1.03 | | 11.99 |
| 5 years | 1.03 | | 11.99 |
| 10 years | 1.03 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 01/04/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/02/26 | Fiscal year | Chief Executive Officer | 6,65,984 | 2.8653% | ||
| 05/01/26 | Kairos Venture Investments LLC
| Sell | Company | 2,80,000 | 1.2046% | |
| 27/06/25 | BIOS Capital Management LP
| Buy | Company | 71,428 | 0.3657% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | -7.77% | -84.02% | - | 2.58Cr | |
| -3.74% | -6.32% | +42.70% | +63.37% | 5.52TCr | |
| -0.81% | -0.33% | +27.15% | +81.12% | 5.56TCr | |
| -0.38% | +0.37% | -16.04% | -15.13% | 2.35TCr | |
| -2.82% | -6.72% | -4.74% | +353.58% | 2.24TCr | |
| -4.01% | -2.68% | +12.50% | -12.70% | 2.06TCr | |
| -1.23% | -3.15% | +26.00% | -33.84% | 1.74TCr | |
| -3.34% | -6.96% | +22.02% | +515.48% | 1.52TCr | |
| +0.43% | -0.36% | +50.45% | +181.33% | 1.39TCr | |
| -5.09% | -13.14% | +151.85% | +272.20% | 1.37TCr | |
| Average | -1.33% | -2.85% | +22.79% | +156.16% | 2.38TCr | |
| Weighted average by Cap. | -2.28% | -0.46% | +30.37% | +121.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $1.170 | +8.33% | 1,41,850 |
| 29/26/29 | $1.080 | +1.89% | 59,283 |
| 28/26/28 | $1.060 | -7.83% | 2,14,395 |
| 27/26/27 | $1.150 | -2.54% | 2,26,824 |
| 24/26/24 | $1.180 | -6.35% | 93,561 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.080USD
Average target price
9.978USD
Spread / Average Target
+823.84%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
